Joy Wu, MD, PhD is Vice Chair of Basic and Translational Science and Associate Professor of Medicine at Stanford University School of Medicine. She earned her MD and PhD degrees from Duke University School of Medicine, then completed her residency in Internal Medicine at Brigham and Women’s Hospital and clinical fellowship in Endocrinology at Massachusetts General Hospital.
Dr. Wu directs a basic and translational research program that focuses on skeletal development, the bone marrow hematopoietic and metastatic niche, and stem cell therapies for bone. Her research has been funded by several NIH institutes including NIAMS, NIDDK, NHLBI and NIA, as well as the Mary Kay Foundation and the Department of Defense. She has an active clinical practice in the Osteoporosis Clinic at Stanford and is the Research Chief for Metabolic Bone Disease. She has served on clinical guideline committees for the Endocrine Society, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. Dr. Wu is a Co-Director of the Stanford Internal Medicine Translational Investigator Program, which aims to recruit and mentor physician-scientists. She was a recipient of the NIH Director’s New Innovator Award and the Stanford University Faculty Women’s Forum Allyship Award.
Dr. Wu is a member of the Board of Directors the Endocrine Society and serves as the Board liaison to the Advocacy and Public Outreach Core Committee. She has previously served the Endocrine Society as Co-Chair of the Trainee and Career Development Core Committee, and as a member of the Leadership Development Task Force and the Publications Core Committee, where she chaired the Editor-in-Chief of Endocrinology search committee. Dr. Wu is a standing member of the NIH Skeletal Biology Development and Disease Study Section, an Ambassador of the American Society for Bone and Mineral Research, and has served on the Board of Directors of Advances in Mineral Metabolism.